Across TCGA pan-cancer cohorts, INPP1 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated INPP1 data layer compared with 24 for mass-spec protein and 5 for mass-spec protein.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher INPP1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated INPP1 expression acts as an unfavorable survival marker.
HNSC are the cancer types where INPP1 Mutation most reproducibly stratifies survival.